Xenetic Biosciences, Inc.
- XBIO
- NASDAQ
- Biotechnology
- CAR T Therapy
- Personalized Cancer Treatment
$1.95
Today −2.26%Quote Oct 19, 2026, 02:03 PM UTC
−19.11%over the last month
Max drawdown −33.4%From 1-month high −33.4%3 months −29.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$4.6M
Quote Oct 19
Next earnings
Nov 6
Expected, not confirmed
Latest analyst target
—
Data unavailable
Floor
$1.90
2.3% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about XBIOPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
2